antibodies

Sanofi, AstraZeneca Report Promising RSV Pediatric Data Ahead of Pfizer Adcomm
Sanofi, AstraZeneca Report Promising RSV Pediatric Data Ahead of Pfizer Adcomm
BioSpace
Sanofi
AstraZeneca
RSV
antibodies
infants
clinical trials
Flag link:
AstraZeneca confident new COVID antibody protects against known variants
AstraZeneca confident new COVID antibody protects against known variants
Reuters
AstraZeneca
COVID-19
AZD3152
antibodies
Flag link:
FDA starts review of Sanofi, AZ antibody for RSV prevention
FDA starts review of Sanofi, AZ antibody for RSV prevention
Pharmaphorum
RSV
Sanofi
AstraZeneca
FDA
antibodies
nirsevimab
Flag link:
AbbVie Gains Access to Pulmonary Fibrosis Antibody with $225M DJS Buy
AbbVie Gains Access to Pulmonary Fibrosis Antibody with $225M DJS Buy
BioSpace
AbbVie
M&A
DJS Antibodies
pulmonary fibrosis
antibodies
Flag link:
Versant partners with AbCellera to arm startups with better antibodies
Versant partners with AbCellera to arm startups with better antibodies
BioPharma Dive
AbCellera
Versant Ventures
antibodies
drug development
Flag link:
AstraZeneca picks up suite of new Covid-19 antibodies, shining spotlight on Oxford-tied startup
AstraZeneca picks up suite of new Covid-19 antibodies, shining spotlight on Oxford-tied startup
Endpoints
AstraZeneca
COVID-19
antibodies
RQ Biotechnology
Flag link:
Astellas, Twist Join Forces to Enhance Tumor Immunity
Astellas, Twist Join Forces to Enhance Tumor Immunity
BioSpace
Astellas
Twist Bioscience
R&D
antibodies
tumor immunity
Flag link:
AstraZeneca says no severe virus cases or deaths after taking antibody
AstraZeneca says no severe virus cases or deaths after taking antibody
Morningstar
AstraZeneca
Evusheld
COVID-19
antibodies
Flag link:
Regeneron's bid for COVID-19 drug's full approval hits snag as FDA extends review
Regeneron's bid for COVID-19 drug's full approval hits snag as FDA extends review
Fierce Pharma
Regeneron
REGEN-COV
FDA
COVID-19
antibodies
Flag link:
FDA halts Vir, GSK antibody use in response to COVID subvariant's spread
FDA halts Vir, GSK antibody use in response to COVID subvariant's spread
BioPharma Dive
FDA
GSK
Vir Biotechnology
antibodies
COVID-19
Omicron BA.2
Flag link:
First-Ever Computationally-Designed Antibody Enters Clinical Trials
First-Ever Computationally-Designed Antibody Enters Clinical Trials
BioSpace
Biolojic Design
clinical trials
antibodies
AU-007
Flag link:
Adagio knows its COVID-19 antibody works against old variants. Can it win EUA in the era of omicron?
Adagio knows its COVID-19 antibody works against old variants. Can it win EUA in the era of omicron?
Fierce Biotech
Adagio Therapeutics
FDA
COVID-19
antibodies
ADG20
Flag link:
Sanofi Commits Potential $6B to IGM (Antibodies) in New Collab
Sanofi Commits Potential $6B to IGM (Antibodies) in New Collab
BioSpace
Sanofi
IGM Biosciences
oncology
immunology
antibodies
drug discovery
cancer
Flag link:
Synthetic Antibodies to be Designed with Organoids
Synthetic Antibodies to be Designed with Organoids
Science & Enterprise
antibodies
synthetic antibodies
organoids
Prellis Biologics
Sanofi
Flag link:
Novartis backs Epsilogen's bid to turn 'Cinderella antibody' into new class of cancer drug
Novartis backs Epsilogen's bid to turn 'Cinderella antibody' into new class of cancer drug
Fierce Biotech
Novartis
antibodies
funding
cancer
Epsiologen
Flag link:
FDA bans use of Lilly, Regeneron COVID drugs due to Omicron
FDA bans use of Lilly, Regeneron COVID drugs due to Omicron
Pharmaforum
COVID-19
Eli Lilly
Regeneron
antibodies
Omicron COVID-19 variant
Flag link:
GlaxoSmithKline rushes to accelerate COVID-19 antibody output amid omicron-driven demand
GlaxoSmithKline rushes to accelerate COVID-19 antibody output amid omicron-driven demand
Fierce Pharma
GSK
Vir Biotechnology
COVID-19
antibodies
drug manufacturing
Samsung BioLogics
Flag link:
Prellis, Bristol Myers Squibb collaborate to discover antibodies
Prellis, Bristol Myers Squibb collaborate to discover antibodies
Pharmaceutical Business Review
Prellis Biologics
Bristol Myers Squibb
antibodies
drug discovery
Flag link:
AstraZeneca's COVID therapy becomes first antibody approved for immunocompromised people preexposure
AstraZeneca's COVID therapy becomes first antibody approved for immunocompromised people preexposure
Fierce Pharma
AstraZeneca
COVID-19
antibodies
FDA
Emergency Use Authorization
Flag link:
New data shows GSK-Vir drug works against all Omicron mutations
New data shows GSK-Vir drug works against all Omicron mutations
Reuters
GSK
Vir Biotechnology
COVID-19
antibodies
Omicron COVID-19 variant
Flag link:

Pages